BCLI logo

Brainstorm Cell Therapeutics (BCLI) Debt To Equity Ratio

Annual Debt To Equity

-0.26
+1.10+80.88%

31 December 2023

BCLI Debt To Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Debt To Equity

-0.14
+0.13+48.15%

30 September 2024

BCLI Quarterly Debt To Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCLI Debt To Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+80.9%+87.5%
3 y3 years-230.0%-163.6%
5 y5 years-100.0%+64.1%

BCLI Debt To Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-200.0%+80.9%-104.4%+89.7%
5 y5 years-200.0%+80.9%-104.4%+89.7%
alltimeall time-125.2%+80.9%-100.3%+89.7%

Brainstorm Cell Therapeutics Debt To Equity History

DateAnnualQuarterly
Sept 2024
-
-0.14(-48.1%)
June 2024
-
-0.27(+35.0%)
Mar 2024
-
-0.20(-23.1%)
Dec 2023
-0.26(-80.9%)
-0.26(-76.8%)
Sept 2023
-
-1.12(+31.8%)
June 2023
-
-0.85(+11.8%)
Mar 2023
-
-0.76(-44.1%)
Dec 2022
-1.36(-623.1%)
-1.36(-143.2%)
Sept 2022
-
3.15(+425.0%)
June 2022
-
0.60(+57.9%)
Mar 2022
-
0.38(+46.2%)
Dec 2021
0.26(+30.0%)
0.26(+18.2%)
Sept 2021
-
0.22(+10.0%)
June 2021
-
0.20(+11.1%)
Mar 2021
-
0.18(-10.0%)
Dec 2020
0.20(-205.3%)
0.20(+233.3%)
Sept 2020
-
0.06(-66.7%)
June 2020
-
0.18(-18.2%)
Mar 2020
-
0.22(-215.8%)
Dec 2019
-0.19(<-9900.0%)
-0.19(-51.3%)
Sept 2019
-
-0.39(-38.1%)
June 2019
-
-0.63(-106.7%)
Mar 2019
-
9.34(>+9900.0%)
Dec 2018
0.00(0.0%)
0.00(0.0%)
Sept 2018
-
0.00(0.0%)
June 2018
-
0.00(0.0%)
Mar 2018
-
0.00(0.0%)
Dec 2017
0.00(0.0%)
0.00(0.0%)
Sept 2017
-
0.00(0.0%)
June 2017
-
0.00(0.0%)
Mar 2017
-
0.00(0.0%)
Dec 2016
0.00(0.0%)
0.00(0.0%)
Sept 2016
-
0.00(0.0%)
June 2016
-
0.00(0.0%)
Mar 2016
-
0.00(0.0%)
Dec 2015
0.00(0.0%)
0.00(0.0%)
Sept 2015
-
0.00(0.0%)
June 2015
-
0.00(0.0%)
Mar 2015
-
0.00(0.0%)
Dec 2014
0.00(0.0%)
0.00(0.0%)
Sept 2014
-
0.00(0.0%)
June 2014
-
0.00(0.0%)
Mar 2014
-
0.00(0.0%)
Dec 2013
0.00
0.00(0.0%)
Sept 2013
-
0.00(0.0%)
June 2013
-
0.00(0.0%)
DateAnnualQuarterly
Mar 2013
-
0.00(0.0%)
Dec 2012
0.00(0.0%)
0.00(0.0%)
Sept 2012
-
0.00(0.0%)
June 2012
-
0.00(0.0%)
Mar 2012
-
0.00(0.0%)
Dec 2011
0.00(-100.0%)
0.00(0.0%)
Sept 2011
-
0.00(0.0%)
June 2011
-
0.00(0.0%)
Mar 2011
-
0.00(-100.0%)
Dec 2010
-0.30(+42.9%)
-0.30(+328.6%)
Sept 2010
-
-0.07(<-9900.0%)
June 2010
-
0.00(-100.0%)
Mar 2010
-
3.00(-1528.6%)
Dec 2009
-0.21(0.0%)
-0.21(+110.0%)
Sept 2009
-
-0.10(+11.1%)
June 2009
-
-0.09(-50.0%)
Mar 2009
-
-0.18(-14.3%)
Dec 2008
-0.21(-66.7%)
-0.21(-19.2%)
Sept 2008
-
-0.26(-3.7%)
June 2008
-
-0.27(-52.6%)
Mar 2008
-
-0.57(-9.5%)
Dec 2007
-0.63(+1.6%)
-0.63(-11.3%)
Sept 2007
-
-0.71(+16.4%)
June 2007
-
-0.61(0.0%)
Mar 2007
-
-0.61(-23.8%)
Dec 2006
-0.62(+933.3%)
-
Sept 2006
-
-0.80(-39.8%)
June 2006
-
-1.33(+2116.7%)
Mar 2006
-
-0.06(<-9900.0%)
Mar 2006
-0.06(<-9900.0%)
-
Dec 2005
-
0.00(0.0%)
Sept 2005
-
0.00(0.0%)
June 2005
-
0.00(0.0%)
Mar 2005
0.00(0.0%)
0.00(0.0%)
Dec 2004
-
0.00(0.0%)
Sept 2004
-
0.00(0.0%)
June 2004
-
0.00(0.0%)
Mar 2004
0.00(-100.0%)
0.00(-100.0%)
Dec 2003
-
51.67(+716.3%)
Sept 2003
-
6.33(+268.0%)
June 2003
-
1.72(+67.0%)
Mar 2003
1.03(+442.1%)
1.03(+45.1%)
Dec 2002
-
0.71(-22.0%)
Sept 2002
-
0.91(-2.2%)
June 2002
-
0.93
Mar 2002
0.19
-

FAQ

  • What is Brainstorm Cell Therapeutics annual debt to equity ratio?
  • What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?
  • What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?

What is Brainstorm Cell Therapeutics annual debt to equity ratio?

The current annual debt to equity of BCLI is -0.26

What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high annual debt to equity ratio is 1.03

What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?

Over the past year, BCLI annual debt to equity ratio has changed by +1.10 (+80.88%)

What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?

The current quarterly debt to equity of BCLI is -0.14

What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high quarterly debt to equity ratio is 51.67

What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?

Over the past year, BCLI quarterly debt to equity ratio has changed by +0.98 (+87.50%)